Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission

This study has been completed.

Study NCT00522301 Information provided by National Cancer Institute (NCI)

First Received: August 28, 2007 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)